Intellia Therapeutics Debt to Equity Ratio 2015-2018 | NTLA

Current and historical debt to equity ratio values for Intellia Therapeutics (NTLA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Intellia Therapeutics debt/equity for the three months ending September 30, 2018 was 0.00.
Intellia Therapeutics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.26B 0.00
2018-06-30 $0.00B $0.28B 0.00
2018-03-31 $0.00B $0.30B 0.00
2017-12-31 $0.00B $0.30B 0.00
2017-09-30 $0.00B $0.18B 0.00
2017-06-30 $0.00B $0.19B 0.00
2017-03-31 $0.00B $0.20B 0.00
2016-12-31 $0.00B $0.21B 0.00
2016-09-30 $0.00B $0.22B 0.00
2016-06-30 $0.00B $0.22B 0.00
2016-03-31 $0.00B $-0.03B 0.00
2015-12-31 $0.00B $-0.02B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.00B $-0.01B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.683B $0.026B
Intellia Therapeutics is a leading genome editing company, focused on developing therapeutics utilizing a biological tool known as CRISPR-Cas9 system. It believes the CRISPR-Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. The Cas9 protein acts like a pair of molecular scissors that initiates the natural cellular repair process to knockout, repair or insert a gene. The guide RNA sequence recognizes and directs the Cas9 to a specific target deoxyribonucleic acid (DNA) sequence. The Company's sentinel in vivo programs focus on the use of Lipid Nanoparticle (LNPs) for delivery of the CRISPR/Cas9 complex to the liver. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR-Cas9 technology and create a new class of therapeutic products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.391B 13.84
Gilead Sciences (GILD) United States $84.823B 10.21
Biogen (BIIB) United States $63.376B 12.83
Illumina (ILMN) United States $47.990B 55.90
Celgene (CELG) United States $47.689B 9.25
Vertex Pharmaceuticals (VRTX) United States $43.460B 75.92
Regeneron Pharmaceuticals (REGN) United States $41.246B 20.90
Alexion Pharmaceuticals (ALXN) United States $24.413B 16.71
BioMarin Pharmaceutical (BMRN) United States $16.579B 0.00
Incyte (INCY) United States $14.099B 389.71
Seattle Genetics (SGEN) United States $9.686B 0.00
Exact Sciences (EXAS) United States $8.395B 0.00
Sarepta Therapeutics (SRPT) United States $7.987B 0.00
BeiGene (BGNE) Cayman Islands $7.952B 0.00
QIAGEN (QGEN) Netherlands $7.897B 25.25
Alnylam Pharmaceuticals (ALNY) United States $7.792B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.412B 47.39
Exelixis (EXEL) United States $6.288B 17.82
Bio-Techne Corp (TECH) United States $5.709B 38.57
Bluebird Bio (BLUE) United States $5.655B 0.00
Galapagos (GLPG) Belgium $5.335B 0.00
Amarin (AMRN) Ireland $5.186B 0.00
Alkermes (ALKS) Ireland $5.100B 3282.00
Immunomedics (IMMU) United States $3.567B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.490B 0.00
Guardant Health (GH) United States $3.414B 0.00
Array BioPharma (ARRY) United States $3.403B 0.00
Horizon Pharma Public (HZNP) Ireland $3.341B 13.74
ARGENX SE-ADR (ARGX) Netherlands $3.280B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.203B 0.00
Allogene Therapeutics (ALLO) United States $3.185B 0.00
Emergent Biosolutions (EBS) United States $3.106B 26.16
Ligand Pharmaceuticals (LGND) United States $2.909B 22.25
Akcea Therapeutics (AKCA) United States $2.781B 0.00
Ascendis Pharma (ASND) Denmark $2.742B 0.00
Allakos (ALLK) United States $2.556B 0.00
Repligen (RGEN) United States $2.513B 78.49
Genomic Health (GHDX) United States $2.505B 84.56
Blueprint Medicines (BPMC) United States $2.468B 0.00
China Biologic Products (CBPO) China $2.386B 16.99
Myriad Genetics (MYGN) United States $2.329B 23.07
Ultragenyx Pharmaceutical (RARE) United States $2.327B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.210B 0.00
Global Blood Therapeutics (GBT) United States $2.206B 0.00
Halozyme Therapeutics (HALO) United States $2.193B 48.94
MyoKardia (MYOK) United States $2.145B 0.00
Acceleron Pharma (XLRN) United States $2.092B 0.00
Arena Pharmaceuticals (ARNA) United States $2.030B 0.00
Amicus Therapeutics (FOLD) United States $1.989B 0.00
Denali Therapeutics (DNLI) United States $1.972B 0.00
Atara Biotherapeutics (ATRA) United States $1.904B 0.00
AnaptysBio (ANAB) United States $1.831B 0.00
Reata Pharmaceuticals (RETA) United States $1.767B 0.00
Innoviva (INVA) United States $1.698B 9.61
CRISPR Therapeutics AG (CRSP) Switzerland $1.697B 0.00
REGENXBIO (RGNX) United States $1.639B 21.98
Biohaven Pharmaceutical Holding (BHVN) United States $1.519B 0.00
Spark Therapeutics (ONCE) United States $1.513B 0.00
WAVE Life Sciences (WVE) Singapore $1.456B 0.00
Medicines (MDCO) United States $1.408B 0.00
Cambrex (CBM) United States $1.397B 10.44
Vanda Pharmaceuticals (VNDA) United States $1.376B 109.33
Editas Medicine (EDIT) United States $1.360B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.359B 0.00
Rubius Therapeutics (RUBY) United States $1.348B 0.00
Aimmune Therapeutics (AIMT) United States $1.340B 0.00
Mirati Therapeutics (MRTX) United States $1.313B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.313B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.273B 0.00
NeoGenomics (NEO) United States $1.238B 101.92
ORCHARD THERAPT (ORTX) United Kingdom $1.224B 0.00
Myovant Sciences (MYOV) United Kingdom $1.200B 0.00
Lion Biotechnologies (IOVA) United States $1.192B 0.00
Sangamo Therapeutics (SGMO) United States $1.172B 0.00
G1 THERAPEUTICS (GTHX) United States $1.135B 0.00
Insmed (INSM) United States $1.129B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.123B 0.00
Clovis Oncology (CLVS) United States $1.094B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.088B 0.00
Apellis Pharmaceuticals (APLS) United States $1.051B 0.00
UniQure (QURE) Netherlands $1.049B 0.00
Fate Therapeutics (FATE) United States $1.026B 0.00
Audentes Therapeutics (BOLD) United States $0.987B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.987B 0.00
Retrophin (RTRX) United States $0.987B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.968B 0.00
Novavax (NVAX) United States $0.923B 0.00
DBV Technologies (DBVT) France $0.870B 0.00
Puma Biotechnology (PBYI) United States $0.861B 0.00
Solid Biosciences (SLDB) United States $0.831B 0.00
Athenex (ATNX) United States $0.801B 0.00
Cellectis (CLLS) France $0.776B 0.00
Acorda Therapeutics (ACOR) United States $0.769B 9.75
Lexicon Pharmaceuticals (LXRX) United States $0.769B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.762B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.759B 0.00
Intra-Cellular Therapies (ITCI) United States $0.742B 0.00
Vericel (VCEL) United States $0.741B 0.00
Aptinyx (APTX) United States $0.741B 0.00
AC Immune SA (ACIU) Switzerland $0.737B 0.00
Revance Therapeutics (RVNC) United States $0.736B 0.00
Heska (HSKA) United States $0.734B 60.04
Y-mAbs Therapeutics (YMAB) United States $0.732B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.697B 0.00
Principia Biopharma (PRNB) United States $0.684B 0.00
UNITY Biotechnology (UBX) $0.673B 0.00
Dynavax Technologies (DVAX) United States $0.666B 0.00
CytomX Therapeutics (CTMX) United States $0.665B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.665B 0.00
Scholar Rock Holding (SRRK) United States $0.662B 0.00
Coherus BioSciences (CHRS) United States $0.662B 0.00
Gritstone Oncology (GRTS) United States $0.644B 0.00
Viking Therapeutics (VKTX) United States $0.642B 0.00
InflaRx (IFRX) Germany $0.637B 0.00
ANI Pharmaceuticals (ANIP) United States $0.629B 12.03
UROGEN PHARMA (URGN) Israel $0.612B 0.00
Eidos Therapeutics (EIDX) United States $0.598B 0.00
AVROBIO (AVRO) United States $0.584B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.580B 0.00
Kezar Life Sciences (KZR) United States $0.573B 0.00
Arcus Biosciences (RCUS) United States $0.557B 0.00
Cara Therapeutics (CARA) United States $0.552B 0.00
TWIST BIOSCIENC (TWST) United States $0.549B 0.00
ObsEva SA (OBSV) Switzerland $0.543B 0.00
Kura Oncology (KURA) United States $0.534B 0.00
RA PHARMCTL INC (RARX) United States $0.528B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.527B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.487B 0.00
Prothena (PRTA) Ireland $0.467B 0.00
Epizyme (EPZM) United States $0.466B 0.00
Inovio Pharmaceuticals (INO) United States $0.463B 0.00
Replimune (REPL) United States $0.463B 0.00
Osiris Therapeutics (OSIR) United States $0.460B 0.00
Arvinas (ARVN) United States $0.459B 0.00
BeyondSpring (BYSI) United States $0.458B 0.00
Zymeworks (ZYME) Canada $0.451B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.431B 0.00
Anika Therapeutics (ANIK) United States $0.430B 17.78
PDL BioPharma (PDLI) United States $0.426B 6.95
Cytokineticsorporated (CYTK) United States $0.421B 0.00
Zealand Pharma (ZEAL) Denmark $0.406B 4.47
ZIOPHARM Oncology Inc (ZIOP) United States $0.404B 0.00
Kindred Biosciences (KIN) United States $0.403B 0.00
Sinovac Biotech (SVA) China $0.403B 0.00
Senesco Technologies (ELOX) United States $0.395B 0.00
Mesoblast (MESO) Australia $0.389B 0.00
MediciNova (MNOV) United States $0.371B 0.00
Evelo Biosciences (EVLO) United States $0.362B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.362B 0.00
Krystal Biotech (KRYS) United States $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.355B 0.00
Abeona Therapeutics (ABEO) United States $0.353B 0.00
ResTORbio (TORC) United States $0.346B 0.00
Five Prime Therapeutics (FPRX) United States $0.342B 0.00
MeiraGTx Holdings (MGTX) United States $0.331B 0.00
Liquidia Technologies (LQDA) United States $0.331B 0.00
Stemline Therapeutics (STML) United States $0.329B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.327B 0.00
Sorrento Therapeutics (SRNE) United States $0.319B 52.20
Verastem (VSTM) United States $0.299B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.293B 0.00
Agenus (AGEN) United States $0.290B 0.00
Merus (MRUS) Netherlands $0.282B 0.00
Albireo Pharma (ALBO) United States $0.281B 0.00
Kadmon Holdings (KDMN) United States $0.279B 0.00
Athersys (ATHX) United States $0.272B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.270B 0.00
MannKind (MNKD) United States $0.268B 0.00
Intec Pharma (NTEC) Israel $0.267B 0.00
Syros Pharmaceuticals (SYRS) United States $0.265B 0.00
Seres Therapeutics (MCRB) United States $0.261B 0.00
Kodiak Sciences (KOD) United States $0.258B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.254B 0.00
Geron (GERN) United States $0.253B 0.00
BioDelivery Sciences (BDSI) United States $0.251B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.244B 0.00
Arbutus Biopharma (ABUS) Canada $0.243B 0.00
Sutro Biopharma (STRO) United States $0.234B 0.00
Magenta Therapeutics (MGTA) United States $0.229B 0.00
Celcuity (CELC) United States $0.227B 0.00
Adverum Biotechnologies (ADVM) United States $0.226B 0.00
Aduro Biotech (ADRO) United States $0.218B 0.00
PSivida (EYPT) United States $0.214B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.213B 0.00
LogicBio Therapeutics (LOGC) United States $0.211B 0.00
ADMA Biologics Inc (ADMA) United States $0.210B 0.00
Equillium (EQ) United States $0.209B 0.00
Strongbridge Biopharma (SBBP) United States $0.204B 0.00
Celyad SA (CYAD) Belgium $0.199B 0.00
Synlogic (SYBX) United States $0.194B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.193B 0.00
Kamada (KMDA) Israel $0.189B 17.34
TOCAGEN INC (TOCA) United States $0.182B 0.00
Urovant Sciences (UROV) United States $0.182B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.180B 0.00
Proteostasis Therapeutics (PTI) United States $0.177B 0.00
Kala Pharmaceuticals (KALA) United States $0.174B 0.00
Cohbar (CWBR) United States $0.167B 0.00
Protagonist Therapeutics (PTGX) United States $0.167B 0.00
ChromaDex (CDXC) United States $0.166B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.166B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.165B 0.00
XBiotech (XBIT) United States $0.159B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.158B 0.00
Constellation Pharmaceuticals (CNST) United States $0.157B 0.00
Allena Pharmaceuticals (ALNA) United States $0.156B 0.00
Compugen (CGEN) Israel $0.156B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.154B 0.00
Unum Therapeutics (UMRX) United States $0.151B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.144B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.139B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
Cerecor (CERC) United States $0.135B 0.00
Menlo Therapeutics (MNLO) United States $0.127B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.124B 0.00
Axovant Sciences (AXON) United Kingdom $0.124B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.122B 0.00
XOMA (XOMA) United States $0.119B 0.00
Organovo Holdings (ONVO) United States $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.115B 0.00
Mersana Therapeutics (MRSN) United States $0.111B 0.00
Spero Therapeutics (SPRO) United States $0.109B 0.00
Eleven Biotherapeutics (SESN) United States $0.108B 0.00
Idera Pharmaceuticals (IDRA) United States $0.108B 0.00
NantKwest (NK) United States $0.107B 0.00
Cue Biopharma (CUE) United States $0.106B 0.00
Selecta Biosciences (SELB) United States $0.106B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.103B 0.00
ETON PHARMACEUT (ETON) United States $0.102B 0.00
PHASEBIO PHARMA (PHAS) United States $0.101B 0.00
VBI Vaccines (VBIV) United States $0.099B 0.00
Pluristem Therapeutics (PSTI) Israel $0.098B 0.00
Anavex Life Sciences (AVXL) United States $0.094B 0.00
Cocrystal Pharma (COCP) United States $0.093B 104.00
Neothetics (EVFM) United States $0.092B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.092B 0.00
Signal Genetics (MGEN) United States $0.091B 0.00
ScPharmaceuticals (SCPH) United States $0.091B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Motif Bio Plc (MTFB) United States $0.090B 0.00
Axsome Therapeutics (AXSM) United States $0.090B 0.00
Aptose Biosciences (APTO) Canada $0.085B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.083B 0.00
Provention Bio (PRVB) United States $0.081B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.078B 0.00
Mustang Bio (MBIO) United States $0.077B 0.00
Cidara Therapeutics (CDTX) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.076B 0.00
OVID THERAPEUTC (OVID) United States $0.074B 0.00
Monster Digital (INNT) United States $0.074B 0.00
ITUS (ANIX) United States $0.074B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.069B 0.00
VTv Therapeutics (VTVT) United States $0.066B 0.00
NewLink Genetics (NLNK) United States $0.065B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Bellerophon Therapeutics (BLPH) United States $0.063B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.063B 0.00
Sophiris Bio (SPHS) United States $0.062B 0.00
BioXcel Therapeutics (BTAI) United States $0.060B 0.00
Alcobra (ARCT) United States $0.060B 0.00
Fortress Biotech (FBIO) United States $0.060B 0.00
Applied Genetic Technologies (AGTC) United States $0.059B 0.00
Ophthotech (OPHT) United States $0.057B 0.00
Evogene (EVGN) Israel $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.054B 0.00
Arsanis (ASNS) United States $0.054B 0.00
Vaccinex (VCNX) United States $0.053B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
Versartis (ARAV) United States $0.049B 4.34
Trevena (TRVN) United States $0.048B 0.00
AEterna Zentaris (AEZS) United States $0.047B 8.91
Caladrius Biosciences (CLBS) United States $0.047B 0.00
OncoSec Medical (ONCS) United States $0.046B 0.00
Entera Bio (ENTX) Israel $0.045B 0.00
Aptevo Therapeutics (APVO) United States $0.044B 0.00
Leap Therapeutics (LPTX) United States $0.043B 0.00
Celldex Therapeutics (CLDX) United States $0.043B 0.00
Zosano Pharma (ZSAN) United States $0.042B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Clearside Biomedical (CLSD) United States $0.040B 0.00
Celsion (CLSN) United States $0.037B 0.00
Proteon Therapeutics (PRTO) United States $0.035B 0.00
Galena Biopharma (SLS) United States $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Eyenovia (EYEN) United States $0.034B 0.00
Moleculin Biotech (MBRX) United States $0.034B 0.00
Histogenics (HSGX) United States $0.034B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.031B 5.00
TRACON Pharmaceuticals (TCON) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
AZURRX BIOPHARM (AZRX) United States $0.030B 0.00
GTx (GTXI) United States $0.029B 0.00
Curis (CRIS) United States $0.028B 0.00
DiaMedica Therapeutics (DMAC) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
IMMURON LTD (IMRN) Australia $0.026B 0.00
OvaScience (MLND) United States $0.025B 0.00
Vical (VICL) United States $0.025B 0.00
Adial Pharmaceuticals (ADIL) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Aileron Therapeutics (ALRN) United States $0.018B 0.00
GENPREX INC (GNPX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Therapix Biosciences (TRPX) Israel $0.016B 8.11
CytRx (CYTR) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Cellect Biotechnology (APOP) Israel $0.015B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.014B 0.00
Edge Therapeutics (EDGE) United States $0.014B 0.00
ATyr Pharma (LIFE) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.013B 0.00
Gemphire Therapeutics (GEMP) United States $0.013B 0.00
Advaxis (ADXS) United States $0.013B 0.00
Prana Biotechnology (PRAN) Australia $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Genetic Technologies (GENE) Australia $0.012B 0.00
Vital Therapies (VTL) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Neuralstem (CUR) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
RestorGenex (DFFN) United States $0.000B 0.00